Brandt Tells NIK There May Be No Exceptions To DRG Regulations, Maybe a Few At Comprehensive Centers
In Brief: DCT Board Rejects Move to Count Individual P01 Projects Toward The NIH Total Of 5,000 Grants
Largest Oncological Society Exerts Clout, Getting Results
DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ









